GLP-1 Medications
Overview of FDA-approved and compounded GLP-1 medications available through US telehealth providers.
Semaglutide
Wegovy · Ozempic · Rybelsus
Dosing: Once-weekly injection (Wegovy/Ozempic) or daily oral tablet (Rybelsus)
FDA-approved for chronic weight management (Wegovy) and type 2 diabetes (Ozempic)
Tirzepatide
Zepbound · Mounjaro
Dosing: Once-weekly injection
FDA-approved for chronic weight management (Zepbound) and type 2 diabetes (Mounjaro)
Wegovy
Novo Nordisk
Dosing: 0.25mg → 2.4mg weekly injection (dose escalation over 16 weeks)
FDA-approved 2021 for chronic weight management in adults
Ozempic
Novo Nordisk
Dosing: 0.5mg → 2mg weekly injection
FDA-approved for type 2 diabetes; widely prescribed off-label for weight loss
Zepbound
Eli Lilly
Dosing: 2.5mg → 15mg weekly injection (dose escalation)
FDA-approved 2023 for chronic weight management in adults
Compounded Semaglutide
Various compounding pharmacies
Dosing: Custom dose — typically same schedule as brand versions
Not FDA-approved individually; compounded under 503A/503B pharmacy regulations